The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Malaria Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Malaria Diagnostics is the procedure to test if the patient have the Malaria .
The global Malaria Diagnostics market size is expected to reach US$ 820.5 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Malaria Diagnostics in various end use industries. The expanding demands from the Clinics, Hospitals and Laboratories,, are propelling Malaria Diagnostics market. Rapid Diagnostic Tests (RDT), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Malaria Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Malaria Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Malaria Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Malaria Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Malaria Diagnostics covered in this report include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare and Wako Chemicals, Inc., etc.
The global Malaria Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Global Malaria Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Malaria Diagnostics market, Segment by Type:
Rapid Diagnostic Tests (RDT)
Molecular Diagnostics
Microscopy
Global Malaria Diagnostics market, by Application
Clinics
Hospitals
Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Malaria Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Malaria Diagnostics is the procedure to test if the patient have the Malaria .
The global Malaria Diagnostics market size is expected to reach US$ 820.5 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Malaria Diagnostics in various end use industries. The expanding demands from the Clinics, Hospitals and Laboratories,, are propelling Malaria Diagnostics market. Rapid Diagnostic Tests (RDT), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Malaria Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Malaria Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Malaria Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Malaria Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Malaria Diagnostics covered in this report include Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare and Wako Chemicals, Inc., etc.
The global Malaria Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Ortho-Clinical Diagnostics
Premier Medical Corporation Ltd.
Siemens Healthcare
Wako Chemicals, Inc.
Global Malaria Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Malaria Diagnostics market, Segment by Type:
Rapid Diagnostic Tests (RDT)
Molecular Diagnostics
Microscopy
Global Malaria Diagnostics market, by Application
Clinics
Hospitals
Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Malaria Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Malaria Diagnostics
1.1 Malaria Diagnostics Market Overview
1.1.1 Malaria Diagnostics Product Scope
1.1.2 Malaria Diagnostics Market Status and Outlook
1.2 Global Malaria Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Malaria Diagnostics Market Size by Region (2018-2029)
1.4 Global Malaria Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Malaria Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Malaria Diagnostics Market Size (2018-2029)
1.6.1 North America Malaria Diagnostics Market Size (2018-2029)
1.6.2 Europe Malaria Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Malaria Diagnostics Market Size (2018-2029)
1.6.4 Latin America Malaria Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Malaria Diagnostics Market Size (2018-2029)
2 Malaria Diagnostics Market by Type
2.1 Introduction
2.1.1 Rapid Diagnostic Tests (RDT)
2.1.2 Molecular Diagnostics
2.1.3 Microscopy
2.2 Global Malaria Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Malaria Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Malaria Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Malaria Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Malaria Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Malaria Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Malaria Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Malaria Diagnostics Revenue Breakdown by Type (2018-2029)
3 Malaria Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Laboratories
3.2 Global Malaria Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Malaria Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Malaria Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Malaria Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Malaria Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Malaria Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Malaria Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Malaria Diagnostics Revenue Breakdown by Application (2018-2029)
4 Malaria Diagnostics Competition Analysis by Players
4.1 Global Malaria Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Malaria Diagnostics as of 2022)
4.3 Date of Key Players Enter into Malaria Diagnostics Market
4.4 Global Top Players Malaria Diagnostics Headquarters and Area Served
4.5 Key Players Malaria Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Malaria Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Malaria Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Beckman Coulter/Danaher
5.2.1 Beckman Coulter/Danaher Profile
5.2.2 Beckman Coulter/Danaher Main Business
5.2.3 Beckman Coulter/Danaher Malaria Diagnostics Products, Services and Solutions
5.2.4 Beckman Coulter/Danaher Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Beckman Coulter/Danaher Recent Developments
5.3 Bio-Rad Laboratories, Inc.
5.3.1 Bio-Rad Laboratories, Inc. Profile
5.3.2 Bio-Rad Laboratories, Inc. Main Business
5.3.3 Bio-Rad Laboratories, Inc. Malaria Diagnostics Products, Services and Solutions
5.3.4 Bio-Rad Laboratories, Inc. Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Life Technology Recent Developments
5.4 Life Technology
5.4.1 Life Technology Profile
5.4.2 Life Technology Main Business
5.4.3 Life Technology Malaria Diagnostics Products, Services and Solutions
5.4.4 Life Technology Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Life Technology Recent Developments
5.5 Novartis Diagnostics., Ltd.
5.5.1 Novartis Diagnostics., Ltd. Profile
5.5.2 Novartis Diagnostics., Ltd. Main Business
5.5.3 Novartis Diagnostics., Ltd. Malaria Diagnostics Products, Services and Solutions
5.5.4 Novartis Diagnostics., Ltd. Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Diagnostics., Ltd. Recent Developments
5.6 Ortho-Clinical Diagnostics
5.6.1 Ortho-Clinical Diagnostics Profile
5.6.2 Ortho-Clinical Diagnostics Main Business
5.6.3 Ortho-Clinical Diagnostics Malaria Diagnostics Products, Services and Solutions
5.6.4 Ortho-Clinical Diagnostics Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Ortho-Clinical Diagnostics Recent Developments
5.7 Premier Medical Corporation Ltd.
5.7.1 Premier Medical Corporation Ltd. Profile
5.7.2 Premier Medical Corporation Ltd. Main Business
5.7.3 Premier Medical Corporation Ltd. Malaria Diagnostics Products, Services and Solutions
5.7.4 Premier Medical Corporation Ltd. Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Premier Medical Corporation Ltd. Recent Developments
5.8 Siemens Healthcare
5.8.1 Siemens Healthcare Profile
5.8.2 Siemens Healthcare Main Business
5.8.3 Siemens Healthcare Malaria Diagnostics Products, Services and Solutions
5.8.4 Siemens Healthcare Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthcare Recent Developments
5.9 Wako Chemicals, Inc.
5.9.1 Wako Chemicals, Inc. Profile
5.9.2 Wako Chemicals, Inc. Main Business
5.9.3 Wako Chemicals, Inc. Malaria Diagnostics Products, Services and Solutions
5.9.4 Wako Chemicals, Inc. Malaria Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Wako Chemicals, Inc. Recent Developments
6 North America
6.1 North America Malaria Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Malaria Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Malaria Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Malaria Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Malaria Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Malaria Diagnostics Market Dynamics
11.1 Malaria Diagnostics Industry Trends
11.2 Malaria Diagnostics Market Drivers
11.3 Malaria Diagnostics Market Challenges
11.4 Malaria Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
